title: A randomized, double-blind, placebo-controlled trial of oral montelukast in acute asthma exacerbation.
abstract: BACKGROUND
  Leukotriene receptor antagonists (LTRAs) are well established in the management of outpatient asthma. However, there is very little information as to their role in acute asthma exacerbations. We hypothesized that LTRAs may accelerate lung function recovery when given in an acute exacerbation.
  
  
  METHODS
  A randomized, double blind, placebo-controlled trial was conducted at the Aga Khan University Hospital to assess the efficacy of oral montelukast on patients of 16 years of age and above who were hospitalized with acute asthma exacerbation. The patients were given either montelukast or placebo along with standard therapy throughout the hospital stay for acute asthma. Improvements in lung function and duration of hospital stay were monitored.
  
  
  RESULTS
  100 patients were randomized; their mean age was 52 years (SD +/- 18.50). The majority were females (79%) and non-smokers (89%). The mean hospital stay was 3.70 ± 1.93 days with 80% of patients discharged in 3 days. There was no significant difference in clinical symptoms, PEF over the course of hospital stay (p = 0.20 at day 2 and p = 0.47 at day 3) and discharge (p = 0.15), FEV1 at discharge (p = 0.29) or length of hospital stay (p = 0.90) between the two groups. No serious adverse effects were noted during the course of the study.
  
  
  CONCLUSIONS
  Our study suggests that there is no benefit of addition of oral montelukast over conventional treatment in the management of acute asthma attack.
  
  
  BACKGROUND
  
  
  
  BACKGROUND
  375-Med/ERC-04.
authors.affiliation: Section of Pulmonary and Critical Care Medicine, Department of Medicine, The Aga Khan University Hospital, Stadium Road, PO Box 3500, Karachi 74800, Pakistan. ali.zubairi@aku.edu
authors.forename: Ali Bin Sarwar
authors.initials: AB
authors.lastname: Zubairi
authors.forename: Nawal
authors.initials: N
authors.lastname: Salahuddin
authors.forename: Ali
authors.initials: A
authors.lastname: Khawaja
authors.forename: Safia
authors.initials: S
authors.lastname: Awan
authors.forename: Adil Aijaz
authors.initials: AA
authors.lastname: Shah
authors.forename: Ahmed Suleman
authors.initials: AS
authors.lastname: Haque
authors.forename: Shahid Javed
authors.initials: SJ
authors.lastname: Husain
authors.forename: Nisar
authors.initials: N
authors.lastname: Rao
authors.forename: Javaid Ahmad
authors.initials: JA
authors.lastname: Khan
mesh_terms: D000085:Acetates / Q000008:administration & dosage*; D000208:Acute Disease; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology*; D003521:Cyclopropanes; D004311:Double-Blind Method; D005260:Female; D005541:Forced Expiratory Volume / Q000187:drug effects; D006801:Humans; D020024:Leukotriene Antagonists / Q000008:administration & dosage*; D008168:Lung / Q000187:drug effects* / Q000276:immunology / Q000502:physiology; D008297:Male; D008875:Middle Aged; D010366:Peak Expiratory Flow Rate / Q000187:drug effects; D010919:Placebos; D011804:Quinolines / Q000008:administration & dosage*; D020127:Recovery of Function / Q000187:drug effects; D013440:Sulfides; D016896:Treatment Outcome
chemical_list: D000085:Acetates; D003521:Cyclopropanes; D020024:Leukotriene Antagonists; D010919:Placebos; D011804:Quinolines; D013440:Sulfides; C093875:montelukast
references.citation: J Asthma. 2012 Aug;49(6):649-56
references.pmid: 22742205
references.citation: Pediatr Emerg Care. 2008 Jan;24(1):21-7
references.pmid: 18165796
references.citation: Am J Med. 1978 Apr;64(4):622-8
references.pmid: 645728
references.citation: MMWR Surveill Summ. 2002 Mar 29;51(1):1-13
references.pmid: 12420904
references.citation: Chest. 2004 Nov;126(5):1480-9
references.pmid: 15539716
references.citation: Thorax. 2000 Apr;55(4):260-5
references.pmid: 10722763
references.citation: Ann Allergy Asthma Immunol. 2010 Feb;104(2):161-71
references.pmid: 20306820
references.citation: Chest. 1999 Apr;115(4):919-27
references.pmid: 10208187
references.citation: Am J Respir Crit Care Med. 2003 Feb 15;167(4):528-33
references.pmid: 12456380
references.citation: J Asthma. 2012 Feb;49(1):45-50
references.pmid: 22204276
references.citation: Thorax. 2011 Jan;66(1):7-11
references.pmid: 20956393
references.citation: J Clin Epidemiol. 1993 Dec;46(12):1395-402
references.pmid: 8263566
references.citation: N Engl J Med. 2007 Nov 1;357(18):1841-54
references.pmid: 17978293
references.citation: Ann Emerg Med. 1995 Jul;26(1):6-11
references.pmid: 7793723
references.citation: Am J Respir Crit Care Med. 1997 Feb;155(2):454-8
references.pmid: 9032178
references.citation: Cochrane Database Syst Rev. 2001;(1):CD002178
references.pmid: 11279756
references.citation: Ann Intern Med. 1999 Mar 16;130(6):487-95
references.pmid: 10075616
references.citation: Thorax. 2004 Feb;59(2):100-4
references.pmid: 14760145
references.citation: Arch Dis Child. 2002 Oct;87(4):287-90
references.pmid: 12243996
references.citation: Lancet. 2006 Aug 26;368(9537):733-43
references.pmid: 16935684
references.citation: Arch Dis Child. 2010 Jul;95(7):540-3
references.pmid: 20522464
references.citation: J Pak Med Assoc. 1995 Feb;45(2):46-50
references.pmid: 7602746